Particular attention should also be given to male CD patients below 30 years of age, in whom the thiopurine plus anti TNF combination has been shown to increase the risk for hepatosplenic T-cell lymphoma—a very rare and aggressive cancer—if used for more than 2 years [27]. Here, TNF is linked to cancer.